Please assess the completion status of the following clinical trial:

Trial Title: OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Registered male or female primary Liver transplant candidate~* Age ≥18 years old~* Signed: 1) written informed consent document and 2) authorization to use and disclose protected health information~Exclusion Criteria:~* Acute, fulminant liver failure~* Prior solid organ or bone marrow transplant~* Chronic use of hemodialysis or diagnosis of chronic renal failure, defined as chronic serum creatinine of \>3 mg/dl for \>2 weeks and/or requiring hemodialysis~* Multi-organ transplant~* Ventilator dependent~* Dependent on \> 1 IV inotrope to maintain hemodynamics

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- OCS Liver System (Type: EXPERIMENTAL): OCS Liver System
- Control (Type: OTHER): Standard of care (ice)

Based on this trial design, predict the completion outcome and termination type (if applicable).